Cargando…
Mammaglobin as a potential molecular target for breast cancer drug delivery
BACKGROUND: Mammaglobin (MAM) has been used as a specific molecular marker for breast cancer diagnosis. Recently, several groups of researchers proposed a number of therapeutic strategies targeting this molecule. Some of the strategies are based upon an essential but not demonstrated hypothesis – ma...
Autores principales: | Zuo, Lian, Li, Ly, Wang, Qian, Fleming, Timothy P, You, Shaojin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662795/ https://www.ncbi.nlm.nih.gov/pubmed/19309500 http://dx.doi.org/10.1186/1475-2867-9-8 |
Ejemplares similares
-
Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016) -
In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells
por: Hassan, Eman M., et al.
Publicado: (2017) -
The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma
por: Milosevic, Bojan, et al.
Publicado: (2023) -
Evaluation of Serum Mammaglobin as an Alternative Biomarker in the Diagnosis of Breast Tumors
por: Fatima, Maira, et al.
Publicado: (2022) -
Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)